Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
New words:
acute, Ambrose, antitrust, BLA, calendar, cautioned, central, Certified, chronic, clearance, concomitant, contemplated, Cut, cytoDRiVE, differentiated, discover, diversifying, Division, Endoscopy, Ernst, essential, excluding, favorable, GILTI, grow, home, immune, infusion, inhibitor, Israel, JDCA, joined, joint, Kristen, LLP, low, musculoskeletal, neuropathic, November, Obsidian, precisely, purely, Qualitative, Quantitative, reader, rejection, reliance, selective, sensory, Skyhawk, territorial, thereunder, tolerability, UK, undue, University, Virginia, vivo, waiting, Young
Removed:
abrupt, accounted, adversely, affecting, approximating, ASC, Assuming, attributed, authorization, award, began, British, broadly, Canadian, CFTR, cloud, Codification, collected, combined, computing, conductance, conducted, conservative, cumulative, decline, deficit, derivative, directly, disclaim, distributed, Dollar, economy, entity, Euro, exacerbate, exercisable, face, final, forego, foregoing, fourth, French, gene, goodwill, guide, healthcare, hemoglobinopathy, identifying, immaterial, implemented, indirectly, influenza, initial, interact, invoiced, Janssen, limiting, listed, MAA, materialize, measurement, mitigated, mix, natural, negatively, October, opposite, paper, payor, pimodivir, point, portfolio, positively, Pound, predicted, predictive, preserve, pressure, principally, put, qualify, reached, recording, reducing, regulator, relation, released, relied, remained, representing, resale, resulted, RNA, scope, secondary, section, sensitive, separate, serving, sheet, sNDA, Software, specifically, spread, strain, subsequent, subsidiary, Subtopic, supplemental, threshold, trade, trading, transmembrane, travel, unemployment, unknown, utilized, wrong
Filing tables
Filing exhibits
Related press release
Associated VRTX transcripts
VRTX similar filings
Filing view
External links
Exhibit 32.1
SECTION 906 CEO/CFO CERTIFICATION
Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (Subsections (a) and (b) of Section 1350, Chapter 63 of Title 18, United States Code) each of the undersigned officers of Vertex Pharmaceuticals Incorporated, a Massachusetts corporation (the “Company”), does hereby certify, to such officer’s knowledge, that the Quarterly Report on Form 10-Q for the quarter ended March 31, 2021 (the “Form 10-Q”) of the Company fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, and the information contained in the Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of the Company.
Date: | April 30, 2021 | |||||||
/s/ Reshma Kewalramani | ||||||||
Reshma Kewalramani | ||||||||
Chief Executive Officer and President | ||||||||
Date: | April 30, 2021 | |||||||
/s/ Charles F. Wagner, Jr. | ||||||||
Charles F. Wagner, Jr. | ||||||||
Executive Vice President and Chief Financial Officer |